While Johnson & Johnson and other drug companies have announced that they will sell the vaccine to Corona at cost prices, Moderna intends to charge more than any other drug company

A modern company plans to price the vaccine it is developing for the corona virus at a price of $ 50-60 per dose, the Financial Times reports. This is a significantly higher pricing (about $ 11) than planned vaccines from other drug companies, such as Pfizer and Bio-Tech, and much more expensive than vaccines from other drug companies like Johnson & Johnson, which has already announced that it will sell the vaccine (when development is completed and approved) without For-profit, at cost prices only.

Pharmaceutical industry analysts have warned that high pricing could also push up vaccines from other drug companies. According to the Financial Times, Modern's high pricing will apply to the United States and "other high-income countries."

A modern spokesman said in response that the company was in discussions with governments about a possible supply of the vaccine, but did not provide details on the expected pricing, "given the secret nature of the discussions and contracts."

A source close to the discussions told Reuters following the publication that the final price for the vaccine has not yet been determined.

Pfizer, Modern and Mark & ​​Co. said they plan to sell their vaccines at full price, while some of the drug companies, including Johnson & Johnson, have announced their intention to price their vaccines non-profit.